{"title":"具有验证偏差的三类约登指数的区间估计。","authors":"Shuangfei Shi, Shirui Wang, Gengsheng Qin","doi":"10.1080/10543406.2025.2549361","DOIUrl":null,"url":null,"abstract":"<p><p>Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-22"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interval estimation for three-class Youden index with verification bias.\",\"authors\":\"Shuangfei Shi, Shirui Wang, Gengsheng Qin\",\"doi\":\"10.1080/10543406.2025.2549361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.</p>\",\"PeriodicalId\":54870,\"journal\":{\"name\":\"Journal of Biopharmaceutical Statistics\",\"volume\":\" \",\"pages\":\"1-22\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biopharmaceutical Statistics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10543406.2025.2549361\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2025.2549361","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Interval estimation for three-class Youden index with verification bias.
Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.
期刊介绍:
The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:
Drug, device, and biological research and development;
Drug screening and drug design;
Assessment of pharmacological activity;
Pharmaceutical formulation and scale-up;
Preclinical safety assessment;
Bioavailability, bioequivalence, and pharmacokinetics;
Phase, I, II, and III clinical development including complex innovative designs;
Premarket approval assessment of clinical safety;
Postmarketing surveillance;
Big data and artificial intelligence and applications.